The 13-valent pneumonia vaccine is a polysaccharide conjugate vaccine, mainly used to prevent pneumonia in children up to two years old, and has a relatively clear effect on the prevention of more serious pneumonia. It has a relatively clear effect on the prevention of more serious pneumonia and has relatively few side effects. Currently, the 13-valent pneumonia vaccine cannot be given to children over the age of two.